Literature DB >> 20948532

Advances in clinical research methodology for pain clinical trials.

John T Farrar1.   

Abstract

Pain is a ubiquitous phenomenon, but the experience of pain varies considerably from person to person. Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20948532     DOI: 10.1038/nm.2249

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  65 in total

1.  The clinical trial.

Authors:  A B HILL
Journal:  N Engl J Med       Date:  1952-07-24       Impact factor: 91.245

2.  Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.

Authors:  B S Galer; M P Jensen
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

3.  Increasing the reliability and validity of pain intensity measurement in chronic pain patients.

Authors:  M P Jensen; C A McFarland
Journal:  Pain       Date:  1993-11       Impact factor: 6.961

4.  The relationship between the visual analog pain intensity and pain relief scale changes during analgesic drug studies in chronic pain patients.

Authors:  M S Angst; W G Brose; J B Dyck
Journal:  Anesthesiology       Date:  1999-07       Impact factor: 7.892

5.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

Authors:  Didier Bouhassira; Nadine Attal; Haiel Alchaar; François Boureau; Bruno Brochet; Jean Bruxelle; Gérard Cunin; Jacques Fermanian; Patrick Ginies; Aurélie Grun-Overdyking; Hélène Jafari-Schluep; Michel Lantéri-Minet; Bernard Laurent; Gérard Mick; Alain Serrie; Dominique Valade; Eric Vicaut
Journal:  Pain       Date:  2005-01-26       Impact factor: 6.961

6.  Defining the clinically important difference in pain outcome measures.

Authors:  J T Farrar; R K Portenoy; J A Berlin; J L Kinman; B L Strom
Journal:  Pain       Date:  2000-12-01       Impact factor: 6.961

Review 7.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

8.  Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers.

Authors:  Robert N Jamison; Richard H Gracely; Stephen A Raymond; Jonathan G Levine; Barbara Marino; Timothy J Herrmann; Margaret Daly; David Fram; Nathaniel P Katz
Journal:  Pain       Date:  2002-09       Impact factor: 6.961

9.  Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.

Authors:  San Keller; Carla M Bann; Sheri L Dodd; Jeff Schein; Tito R Mendoza; Charles S Cleeland
Journal:  Clin J Pain       Date:  2004 Sep-Oct       Impact factor: 3.442

10.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  23 in total

1.  Cohort study of lumbar percutaneous chemonucleolysis using ethanol gel in sciatica refractory to conservative treatment.

Authors:  Sébastien Touraine; Joël Damiano; Olivia Tran; Jean-Denis Laredo
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma.

Authors:  Doralina L Anghelescu; Jacob L Goldberg; Lane G Faughnan; Jianrong Wu; Shenghua Mao; Wayne L Furman; Victor M Santana; Fariba Navid
Journal:  Pediatr Blood Cancer       Date:  2014-11-08       Impact factor: 3.167

Review 3.  Management of pain in multiple sclerosis: a pharmacological approach.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

4.  Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion.

Authors:  Gang Chen; Chul-Kyu Park; Rou-Gang Xie; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

Review 5.  Mesh fixation in endoscopic inguinal hernia repair: evaluation of methodology based on a systematic review of randomised clinical trials.

Authors:  Hans Lederhuber; Franziska Stiede; Stephan Axer; Ursula Dahlstrand
Journal:  Surg Endosc       Date:  2017-04-14       Impact factor: 4.584

6.  MiR-30b-5p attenuates neuropathic pain by the CYP24A1-Wnt/β-catenin signaling in CCI rats.

Authors:  Junfeng Liao; Jun Liu; Guihua Long; Xiaoyu Lv
Journal:  Exp Brain Res       Date:  2021-11-08       Impact factor: 1.972

7.  Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.

Authors:  Donald W Robinson; Ning Zhao; Fitzroy Dawkins; Ming Qi; Dennis Revicki
Journal:  Qual Life Res       Date:  2013-04-16       Impact factor: 4.147

8.  Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis.

Authors:  Yosuke Tachibana; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2013-05       Impact factor: 2.859

9.  Current challenges in translational pain research.

Authors:  Jianren Mao
Journal:  Trends Pharmacol Sci       Date:  2012-09-06       Impact factor: 14.819

10.  COMT Genotype and Efficacy of Propranolol for TMD Pain: A Randomized Trial.

Authors:  G D Slade; R B Fillingim; R Ohrbach; H Hadgraft; J Willis; S J Arbes; I E Tchivileva
Journal:  J Dent Res       Date:  2020-10-08       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.